These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26602629)

  • 21. Sex-related differences in the relationship between β-amyloid and cognitive trajectories in older adults.
    Lindbergh CA; Casaletto KB; Staffaroni AM; La Joie R; Iaccarino L; Edwards L; Tsoy E; Elahi F; Walters SM; Cotter D; You M; Apple AC; Asken B; Neuhaus J; Rexach JE; Wojta KJ; Rabinovici G; Kramer JH;
    Neuropsychology; 2020 Nov; 34(8):835-850. PubMed ID: 33030915
    [No Abstract]   [Full Text] [Related]  

  • 22. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
    Vemuri P; Lesnick TG; Przybelski SA; Knopman DS; Preboske GM; Kantarci K; Raman MR; Machulda MM; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Rocca WA; Roberts RO; Petersen RC; Jack CR
    Brain; 2015 Mar; 138(Pt 3):761-71. PubMed ID: 25595145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.
    Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P
    Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
    Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
    J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The EMIF-AD PreclinAD study: study design and baseline cohort overview.
    Konijnenberg E; Carter SF; Ten Kate M; den Braber A; Tomassen J; Amadi C; Wesselman L; Nguyen HT; van de Kreeke JA; Yaqub M; Demuru M; Mulder SD; Hillebrand A; Bouwman FH; Teunissen CE; Serné EH; Moll AC; Verbraak FD; Hinz R; Pendleton N; Lammertsma AA; van Berckel BNM; Barkhof F; Boomsma DI; Scheltens P; Herholz K; Visser PJ
    Alzheimers Res Ther; 2018 Aug; 10(1):75. PubMed ID: 30075734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
    Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
    Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.
    Lopresti BJ; Campbell EM; Yu Z; Anderson SJ; Cohen AD; Minhas DS; Snitz BE; Royse SK; Becker CR; Aizenstein HJ; Mathis CA; Lopez OL; Klunk WE; Tudorascu DL
    Neurobiol Aging; 2020 Oct; 94():111-120. PubMed ID: 32603776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid Burden in Obstructive Sleep Apnea.
    Yun CH; Lee HY; Lee SK; Kim H; Seo HS; Bang SA; Kim SE; Greve DN; Au R; Shin C; Thomas RJ
    J Alzheimers Dis; 2017; 59(1):21-29. PubMed ID: 28550245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study.
    Degerman Gunnarsson M; Lindau M; Wall A; Blennow K; Darreh-Shori T; Basu S; Nordberg A; Larsson A; Lannfelt L; Basun H; Kilander L
    Dement Geriatr Cogn Disord; 2010; 29(3):204-12. PubMed ID: 20332638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-Related Effects of the Apolipoprotein E Gene on Brain Function.
    Matura S; Prvulovic D; Hartmann D; Scheibe M; Sepanski B; Butz M; Oertel-Knöchel V; Knöchel C; Karakaya T; Fußer F; Hattingen E; Pantel J
    J Alzheimers Dis; 2016 Mar; 52(1):317-31. PubMed ID: 27003211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of amyloid-cognition relations in cognitively normal older adults.
    Hedden T; Oh H; Younger AP; Patel TA
    Neurology; 2013 Apr; 80(14):1341-8. PubMed ID: 23547267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
    Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
    Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.